Inspire Medical Systems, Inc. (INSP) Stock
1 member of Congress disclosed 1 trade in INSP since 2023: 0 purchases and 1 sale, most recently Daniel Goldman (partial sale, Apr 10, 2023). 4 of the hedge funds AlphaScala tracks reported INSP in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $65.60M. Company insiders reported 0 open-market buys and 1 sale on SEC Form 4 in the 90 days to Oct 21, 2026.
Which members of Congress traded Inspire Medical Systems, Inc. (INSP)?
Most recent: Daniel Goldman (partial sale, Apr 10, 2023); records start Apr 10, 2023.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Dan Goldman D-NY · House | 2023-04-10 | partial sale | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 20, 2026.
See all INSP political trades →Which hedge funds own INSP?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 1.47M | $65.60M | +24% |
| Citadel Ken Griffin | 506K | $22.59M | +28% |
| Renaissance Technologies Jim Simons (founder) | 426K | $19.00M | -9% |
| Millennium Management Israel Englander | 94K | $4.20M | -76% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Inspire Medical Systems, Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 7, 26 | Kelly Jason P | See Remarks | SELL | 963 | $57K |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →INSP price chart
Powered by TradingViewWhat does Inspire Medical Systems, Inc. do?
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neurostimulation device that provides a unique and effective solution for patients who are unable to utilize traditional continuous positive airway pressure (CPAP) devices. Inspire Medical Systems significantly impacts the healthcare sector by offering a less invasive, patient-friendly alternative to surgical treatments for OSA, improving quality of life for those affected by sleep disorders. Headquartered in Minnesota, Inspire Medical Systems continues to expand its presence within the medical device market, collaborating closely with hospitals and medical professionals to enhance sleep health management globally. This company's contributions underscore a growing focus on personalized and technologically advanced approaches to medical challenges, marking its importance in the evolving landscape of healthcare solutions.